Theraclion SA (EPA:ALTHE)
France · Delayed Price · Currency is EUR 0.4850
-0.0150 (-3.00%)
May 14, 2026, 5:27 PM CET
Theraclion Revenue
In the year 2025, Theraclion had annual revenue of 652.00K EUR, down -21.35%. Theraclion had revenue of -292.00K in the half year ending December 31, 2025.
Revenue
652.00K
Revenue Growth
-21.35%
P/S Ratio
56.06
Revenue / Employee
18.11K
Employees
36
Market Cap
36.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 652.00K | -177.00K | -21.35% |
| Dec 31, 2024 | 829.00K | -993.22K | -54.51% |
| Dec 31, 2023 | 1.82M | 586.77K | 47.49% |
| Dec 31, 2022 | 1.24M | -245.50K | -16.58% |
| Dec 31, 2021 | 1.48M | 736.95K | 99.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guerbet | 798.67M |
| Biosynex | 115.13M |
| Diagnostic Medical Systems | 49.47M |
| Median Technologies | 23.47M |
| Novacyt | 22.96M |
| Implanet | 12.47M |
| Bluelinea Société Anonyme | 11.69M |
| Mauna Kea Technologies | 8.91M |
Theraclion News
- 16 days ago - Theraclion’s non-invasive varicose treatment poised for FDA decision - The Armchair Trader